Sep 30 How one drug company fast-tracked the FDA’s review process By Sarah Jane Tribble, Kaiser Health News Any company awarded a voucher can use it for a fast-track government review of one of its future drugs — or it can sell the voucher to another company. Continue reading
Sep 20 After fierce debate, FDA approves first drug for rare form of muscular dystrophy By Liz Szabo, Kaiser Health News The FDA, reacting to lobbying by patients and families, has approved a drug for Duchenne muscular dystrophy, a rare and lethal disease. Continue reading
Sep 11 FDA weighs crackdown that could shut hundreds of stem cell clinics By Usha Lee McFarling, STAT Scientists on Monday will urge the Food and Drug Administration to crack down on rogue clinics across the country that market stem cell treatments. Continue reading
Sep 10 Allergy-proof? Intelligence booster? FDA looks to rein in health claims for baby formula By Sheila Kaplan, STAT The FDA suggested this week that the $3 billion infant formula industry consider proving its claims before selling the products. Continue reading
Sep 09 FDA expresses concern over widely used ovarian cancer screening test By Sheila Kaplan, STAT The Food and Drug Administration on Wednesday warned women and their doctors that current screening tests for ovarian cancer are unreliable. Continue reading
Sep 02 Antibacterial soap may do more harm than good, FDA says By Emily Wishingrad Soaps and wash products labeled “antibacterial” can no longer be sold, the U.S. Food and Drug Administration announced Friday. Continue reading
Aug 26 Infant anti-gas medication linked to spread of hospital infections By Chad Terhune, Kaiser Health News A surprising ingredient — infant gas relief drops — may be contributing to the contamination of medical scopes nationwide. Continue reading
Jun 23 Compromise for GMO food labeling rules struck in Senate By Mary Clare Jalonick, Associated Press Senators have a bipartisan deal to require labeling of genetically modified ingredients nationally, a week before a labeling law in Vermont goes into effect. Continue reading
Jun 21 Federal panel approves first use of CRISPR gene editing in humans By Sharon Begley, STAT A federal biosafety and ethics panel on Tuesday unanimously approved the first study in cancer patients of the genome-editing technology CRISPR/Cas9. Continue reading
Jun 09 If FDA doesn’t issue faster food recalls, consumers face danger, watchdog says By Ricardo Alonso-Zaldivar, Associated Press Despite new legal powers to compel recalls and sophisticated technology to fingerprint pathogens, the Food and Drug Administration allowed some food-safety investigations to drag on, placing consumers in jeopardy of death or serious illness, according to the inspector general's office… Continue reading